These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 16103712)

  • 1. Mechanisms of drug resistance in cancer chemotherapy.
    Luqmani YA
    Med Princ Pract; 2005; 14 Suppl 1():35-48. PubMed ID: 16103712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic drug resistance in brain tumors.
    Phillips PC
    Neurol Clin; 1991 May; 9(2):383-404. PubMed ID: 1682794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein.
    Wurzer G; Herceg Z; Wesierska-Gadek J
    Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular mechanisms of drug resistance.
    Longley DB; Johnston PG
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to antineoplastic treatments: mechanisms, clinical value].
    Bonnal C; Calvo F
    C R Seances Soc Biol Fil; 1996; 190(4):455-66. PubMed ID: 8952896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
    Zhang D; Fan D
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of drug resistance in relapsing colon cancer.
    Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J; Martin C; Callaghan R
    Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response.
    Levenson VV; Davidovich IA; Roninson IB
    Cancer Res; 2000 Sep; 60(18):5027-30. PubMed ID: 11016623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.